Your browser doesn't support javascript.
loading
Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease.
Taron, Jana; Foldyna, Borek; Mayrhofer, Thomas; Osborne, Michael T; Meyersohn, Nandini; Bittner, Daniel O; Puchner, Stefan B; Emami, Hamed; Lu, Michael T; Ferencik, Maros; Pagidipati, Neha J; Douglas, Pamela S; Hoffmann, Udo.
Afiliação
  • Taron J; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Radiology, University Hospital Freiburg, Freiburg, Germany. Electronic address: jana.taron@uniklinik-freiburg.de.
  • Foldyna B; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Mayrhofer T; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany.
  • Osborne MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Meyersohn N; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Bittner DO; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Puchner SB; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Biomedical Imaging and Image-guided Therapy, Medical School of Vienna, Vienna, Austria.
  • Emami H; Cardiovascular Center, University of Michigan, Ann Arbor, USA.
  • Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ferencik M; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Pagidipati NJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Hoffmann U; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
JACC Cardiovasc Imaging ; 14(11): 2186-2195, 2021 11.
Article em En | MEDLINE | ID: mdl-33865792
ABSTRACT

OBJECTIVES:

The purpose of this study was to develop a risk prediction model for patients with nonobstructive CAD.

BACKGROUND:

Among stable chest pain patients, most cardiovascular (CV) events occur in those with nonobstructive coronary artery disease (CAD). Thus, developing tailored risk prediction approaches in this group of patients, including CV risk factors and CAD characteristics, is needed.

METHODS:

In PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) computed tomographic angiography patients, a core laboratory assessed prevalence of CAD (nonobstructive 1% to 49% left main or 1% to 69% stenosis any coronary artery), degree of stenosis (minimal 1% to 29%; mild 30% to 49%; or moderate 50% to 69%), high-risk plaque (HRP) features (positive remodeling, low-attenuation plaque, and napkin-ring sign), segment involvement score (SIS), and coronary artery calcium (CAC). The primary end point was an adjudicated composite of unstable angina pectoris, nonfatal myocardial infarction, and death. Cox regression analysis determined independent predictors in nonobstructive CAD.

RESULTS:

Of 2,890 patients (age 61.7 years, 46% women) with any CAD, 90.4% (n = 2,614) had nonobstructive CAD (mean age 61.6 yrs, 46% women, atherosclerotic cardiovascular disease [ASCVD] risk 16.2%). Composite events were independently predicted by ASCVD risk (hazard ratio [HR] 1.03; p = 0.001), degree of stenosis (30% to 69%; HR 1.91; p = 0.011), and presence of ≥2 HRP features (HR 2.40; p = 0.008). Addition of ≥2 HRP features to 1) ASCVD and CAC; 2) ASCVD and SIS; or 3) ASCVD and degree of stenosis resulted in a statistically significant improvement in model fit (p = 0.0036; p = 0.0176; and p = 0.0318; respectively). Patients with ASCVD ≥7.5%, any HRP, and mild/moderate stenosis had significantly higher event rates than those who did not meet those criteria (3.0% vs. 6.2%; p = 0.007).

CONCLUSIONS:

Advanced coronary plaque features have incremental value over total plaque burden for the discrimination of clinical events in low-risk stable chest pain patients with nonobstructive CAD. This may be a first step to improve prevention in this cohort with the highest absolute risk for CV events.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Estenose Coronária Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Estenose Coronária Idioma: En Ano de publicação: 2021 Tipo de documento: Article